| ²é¿´: 930 | »Ø¸´: 2 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
dadalaziľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
±à¼»Ø¸´µÄÒâ¼û Óеãû¿´¶® Çó´óÏÀ°ïæ ÒÑÓÐ2È˲ÎÓë
|
||
|
ǰ¶Îʱ¼äдµÄÎÄÕ£¬½ñÌìÊÕµ½Á˱༵Ļظ´£¬ÒªÇóÐ޸쬵«ÓÐÒ»¶Î±à¼µÄ»°ÎÒûÀí½â£¬ÈçÏ£º When submitting a revised manuscript, it must be accompanied by specific responses to the issues raised by each reviewer. The revised paper will not be considered further unless it is accompanied by the following documentation of the author(s) specific responses to issues raised by each reviewer. Example: Reviewer 1 Issue 1: A restatement or summary of the issue raised by the reviewer. Discussion A discussion or rebuttal of the issue raised by the reviewer (if necessary). Non-specific statements such as "revised," "accepted," or "acknowledged," will not be accepted. ÎÒµÄÀí½âÊÇÐèÒª¶ÔÉó¸åÈ˵ÄÒâ¼ûÖðÒ»»Ø¸´£¬·ñÔòÊָ彫²»±»½ÓÊÕ¡£ µ«ÊÇÀý×ÓÀïÃæ ¡°Non-specific statements such as "revised," "accepted," or "acknowledged," will not be accepted.¡±ÊÇ˵ÎÒÔÙÐ޸Ļظ´Öв»ÄܳöÏÖrevised accepted Ö®ÀàµÄÓïÑÔÂ𣿷ñÔòÊָ彫±»¾Ü ÊÇÕâÑùÂ𣿠Çë¸ßÊÖÖ¸µãһϠ¶àл£¡ |
» ²ÂÄãϲ»¶
085601²ÄÁϹ¤³Ìר˶Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
293Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ÓÐûÓеÀÌú/ÍÁľµÄÏëµ÷¼ÁÄÏÁÖ£¬¸ø×Ô¼ºÕÐʦµÜÖС«
ÒѾÓÐ6È˻ظ´
085600²ÄÁÏÓ뻯¹¤
ÒѾÓÐ3È˻ظ´
²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á
ÒѾÓÐ4È˻ظ´
085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ
ÒѾÓÐ3È˻ظ´
0854¿É¿çµ÷¼Á£¬Ò»×÷Ò»ÏîºËÐÄÂÛÎÄÎåÏîרÀû£¬Ê¡¡¢¹ú¼¶Ö¤Êé40+ÊýÒ»Ó¢Ò»287
ÒѾÓÐ3È˻ظ´
08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
268Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
26É격
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÒºÏàÉ«Æ×ͼÖ÷·å±¾À´ºÜºÃ£¬Ò»¸öÔºóͻȻ³öÏÖ¼ç·å£¬Çó´óÏÀ°ï棬¸½Í¼¡£
ÒѾÓÐ49È˻ظ´
ÂÛÎijõÉóÒâ¼û»ØÀ´£¬µ«Ã»Óп´¶®ÊÇʲôÒâ˼£¬Çë´ó¼Ò°ïæָµã¸öÏ£¬Ð»Ð»£¡
ÒѾÓÐ8È˻ظ´
Éó¸åÒâ¼û ÇóÖú
ÒѾÓÐ9È˻ظ´
Çë½ÌÒ»ÏÂÉó¸åÈËÒ»¸öÎÊÌ⣬лл£¡£¡
ÒѾÓÐ8È˻ظ´
Éó¸åÈË·µ»ØµÄÒâ¼û£¬Õâ¶Î»°Ã»¿´¶®£¬ÄÜ¿´¶®µÄ´óÏÀ£¬¸øÄú100¸ö½ð±Ò
ÒѾÓÐ9È˻ظ´
Ͷ¸åijÂÛÎĺóÊÕµ½»Ø¸´£¬¸÷λ´óÏÀ¿´¿´ÊÇʲôÇé¿ö£¿
ÒѾÓÐ20È˻ظ´
ÐÞ¸ÄÒâ¼ûû¿´¶®£¬Çó½â
ÒѾÓÐ21È˻ظ´
Éó¸åÈËÒ»¸öÒâ¼û£¬Ã»Óп´¶®£¬Ð»Ð»°ïæ¿´¿´
ÒѾÓÐ11È˻ظ´
elsevierͶ¸åÇóÖú£¬Çó¸÷λ´óÏÀ°ïæ
ÒѾÓÐ9È˻ظ´
¼±Çó£¡ôÈËáºÏ³Éõ£°·µÄ¼òµ¥·½·¨£¬¸÷λ´óÏÀ°ïæ
ÒѾÓÐ17È˻ظ´
ÀÍÉÊÔ¼ÁÁò»¯¼°ºó´¦ÀíÎÊÌâ~~Çó´óÏÀ°ï棡£¡
ÒѾÓÐ10È˻ظ´
ÇóÖú£¬´óÏÀÃÇ£¬°ïæ²éÒ»ÏÂUSP35ÀïÃæµÄcelecoxib£¬×ż±°¡Ð»Ð»
ÒѾÓÐ4È˻ظ´
Çó´óÏÀ°ïæ½â¾öÒ»¸öBÀà´íÎ󣡣¡Ð»Ð»
ÒѾÓÐ5È˻ظ´
Çó´óÏÀÃǰïæ·ÒëÒ»¶ÎÎÄ×Ö£¨ººÓï·Òë³ÉÓ¢Ó
ÒѾÓÐ5È˻ظ´
Ͷ¸å Acta E£¬±à¼¸øµÄÐÞ¸ÄÒâ¼û£¬Çë¸÷λ´óÏÀ¸ø½âÊÍÏ£¬ÔÚÏߵȽá¹û~
ÒѾÓÐ8È˻ظ´
¸÷λ´óÏÀ°ïæ¿´¿´ÎÒµÄÕâ¸öÒº¾§Ð¡·Ö×ÓµÄDSCºÍTGAͼ£¬Çó½â´ð¡£
ÒѾÓÐ14È˻ظ´
ÇóÖú´óÏÀ°ï棬ÓйØmatlabÄ£ÄâÊý¾Ý
ÒѾÓÐ29È˻ظ´
ÇóÖú£ºÍ¶¸åÁË4¸öÔ£¬½ñÌìÊÕµ½ÁËÒ»·âÆæ¹ÖµÄÓʼþ¡£Çë´óÏÀÃǰïæ·ÖÎöÒ»ÏÂ
ÒѾÓÐ16È˻ظ´
µã°å¿ÉÒÔ·Ö¿ª£¬¹ýÖù²»ÐУ¬Çó´óÏÀ°ïæ
ÒѾÓÐ17È˻ظ´
elsevierµÄ±à¼¶ÔÂÛÎÄÌá³öÐÞ¸ÄÒâ¼û£¬Ã»¿´¶®£¬Çë´ó¼Ò°ïæ¿´¿´
ÒѾÓÐ6È˻ظ´

ÒâµÃ¼
¾èÖú¹ó±ö (ÕýʽдÊÖ)
SCI·¢±í¸¨µ¼
- Ó¦Öú: 118 (¸ßÖÐÉú)
- ½ð±Ò: 27.7
- É¢½ð: 5309
- ºì»¨: 48
- Ìû×Ó: 710
- ÔÚÏß: 624.8Сʱ
- ³æºÅ: 2645242
- ×¢²á: 2013-09-10
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
É̼ÒÒѾÖ÷¶¯ÉùÃ÷´Ë»ØÌû¿ÉÄܺ¬ÓÐÐû´«ÄÚÈÝ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
dadalazi: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, Ê®·Ö¸Ðл£¬×îºóµÄ½ð±ÒÈ«²¿ËÍÉÏ 2014-06-20 08:56:46
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
dadalazi: ½ð±Ò+10, ¡ï¡ï¡ïºÜÓаïÖú, Ê®·Ö¸Ðл£¬×îºóµÄ½ð±ÒÈ«²¿ËÍÉÏ 2014-06-20 08:56:46
|
Â¥Ö÷Ôڻظ´Í¬ÐÐÆÀÉóÒâ¼ûµÄʱºò±ØÐëÖðµã»Ø¸´£¬Ôڻظ´µÄʱºò±ØÐë˵Ã÷¸ù¾ÝÿһµãÒâ¼û½øÐÐÁËʲôÑùµÄÐ޸Ļò´¦Àí£¬Èç¹ûÒª·´²µÒâ¼ûµÄ»°£¬Ò²ÒªÌá³öÊʵ±ÀíÓÉÓëÀýÖ¤£¬²»¿ÉÒÔÖ»»Ø¸´¡°ÖªµÀÁË¡±¡¢¡°½ÓÊÜ¡±¡¢¡°ÒÑÐ޸ġ±ÕâÑù×Óº¬ºýµÄ´ð°¸¡£ Äã¿ÉÒԲο¼ÕâÆª¹ØÓڻظ´Í¬ÐÐÆÀÉóÒâ¼ûµÄÎÄÕ£º http://www.editage.cn/insights/»Ø¸´Í¬ÐÐÆÀÉóÒâ¼ûµÄÒªÓë²»Òª £¨ÖÐÎÄÎªÍøÖ·Ò»²¿·Ö£¬ÇëÍêÈ«¸´ÖÆ£© ×£¸£Â¥Ö÷£¡ - Eddy²©Ê¿ |
3Â¥2014-06-19 21:55:04
a2012
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 77 (³õÖÐÉú)
- ½ð±Ò: 1782.2
- É¢½ð: 500
- ºì»¨: 1
- Ìû×Ó: 240
- ÔÚÏß: 415.6Сʱ
- ³æºÅ: 2161276
- ×¢²á: 2012-12-02
- רҵ: ¼¸ºÎѧ
2Â¥2014-06-19 10:03:15













»Ø¸´´ËÂ¥